Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRING
2024-516188-10-00Phase 4Authorised
- Sponsor
- University of Edinburgh
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised trial of aspirin and clopidogrel in intracerebral hemorrhage (ICH), ischemic stroke, myocardial infarction (MI) and 4 more (2 arms), sponsored by University of Edinburgh. Planned start Oct 2025; status: authorised.
02
Drugs
aspirinclopidogrel
03
Conditions
intracerebral hemorrhage (ICH)ischemic strokemyocardial infarction (MI)pulmonary embolism (PE)peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on 2024-516188-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516188-10-00.